schizophrenia |
69 |
covid-19 |
56 |
first-episode psychosis |
49 |
youth mental health |
42 |
negative symptoms |
40 |
depression |
39 |
psychotic disorders |
37 |
early psychosis |
31 |
mental health |
29 |
interprofessional education |
28 |
partnership model |
28 |
predictors |
28 |
social interaction anxiety |
28 |
first-episode schizophrenia |
26 |
psychosis |
26 |
risk factors |
26 |
relapse |
24 |
stigma |
24 |
adolescent |
23 |
depressive symptoms |
22 |
early intervention |
22 |
medical sciences |
22 |
psychiatry and neurology |
22 |
antipsychotics |
21 |
cognitive impairment |
21 |
duration of untreated psychosis |
21 |
epidemiology |
21 |
hong kong |
21 |
social unrest |
21 |
first episode |
20 |
physical activity |
20 |
functioning |
18 |
insight |
18 |
remission |
18 |
executive function |
17 |
medication adherence |
17 |
psychopathology |
17 |
rumination |
17 |
anxiety |
16 |
child psychosocial problems |
16 |
cognition |
16 |
coronavirus |
16 |
delusional disorder |
16 |
functional outcome |
16 |
home confinement |
16 |
post-traumatic stress disorder |
16 |
school closure |
16 |
adolescents |
15 |
age of onset |
15 |
amotivation |
15 |
cost-effectiveness |
15 |
employment |
15 |
stress |
15 |
avolition |
14 |
dopamine |
14 |
first-episode |
14 |
quality of life |
14 |
smartphone overuse |
14 |
mental health services |
13 |
outcome |
13 |
premorbid adjustment |
13 |
prospective study |
13 |
psychotic disorders - diagnosis |
13 |
resilience |
13 |
self-stigma |
13 |
symptomatology |
13 |
validation study |
13 |
cognitive function |
12 |
evaluation |
12 |
experience sampling method |
12 |
longitudinal |
12 |
momentary positive affect |
12 |
network analysis |
12 |
neurocognition |
12 |
recurrence |
12 |
adherence |
11 |
caregivers |
11 |
diminished expression |
11 |
long-term outcomes |
11 |
longitudinal follow-up |
11 |
pandemic |
11 |
pattern glare |
11 |
perceptual distortions |
11 |
prevalence |
11 |
processing speed |
11 |
prospective follow-up |
11 |
self-reference |
11 |
young people |
11 |
youth |
11 |
assessment |
10 |
autism spectrum disorder |
10 |
chinese |
10 |
cognitive functions |
10 |
community-based intervention |
10 |
disengagement |
10 |
double blind |
10 |
early diagnosis |
10 |
f-dopa |
10 |
female |
10 |
maintenance |
10 |
mental health literacy |
10 |
positron emission tomography |
10 |
randomized controlled trial |
10 |
recovery |
10 |
relapse prevention |
10 |
sex difference |
10 |
social cognition |
10 |
stereotyping |
10 |
striatal dopamine capacity synthesis |
10 |
suicide |
10 |
treatment adherence |
10 |
youth-friendly |
10 |
affect |
9 |
autistic disorder |
9 |
community |
9 |
early medical intervention - methods - trends |
9 |
epidemiological youth |
9 |
esm |
9 |
hallucination |
9 |
health education - methods |
9 |
ideas of reference |
9 |
internalized stigma |
9 |
intervention |
9 |
life events |
9 |
loneliness |
9 |
mental health services - trends |
9 |
meta-analysis |
9 |
metabolic syndrome |
9 |
momentary assessment |
9 |
motivational deficits |
9 |
omicron |
9 |
program development |
9 |
psychotic disorders - therapy |
9 |
psychotic-like experiences |
9 |
public stigma |
9 |
schizotypal personality disorder |
9 |
social context |
9 |
traumatic events |
9 |
treatment outcome |
9 |
young adult |
9 |
clozapine |
8 |
cluster analysis |
8 |
cognition disorders - etiology |
8 |
corpus striatum |
8 |
delusions |
8 |
delusions - diagnosis |
8 |
delusions - etiology |
8 |
discontinuation |
8 |
dose-dependent effect |
8 |
eye-gaze perception |
8 |
first episode psychosis |
8 |
growth mixture modeling |
8 |
interview, psychological - methods |
8 |
latent class analysis |
8 |
long-term outcome |
8 |
maintenance treatment |
8 |
mass screening |
8 |
mass screening - methods |
8 |
mentalization |
8 |
mode of onset |
8 |
persistent psychotic experience |
8 |
primary negative symptoms |
8 |
psychiatric status rating scales |
8 |
psychotic disorders - complications |
8 |
ptsd symptoms |
8 |
raclopride |
8 |
schizophrenia - complications |
8 |
schizophrenic psychology |
8 |
self-discrepancy |
8 |
semantic |
8 |
trauma exposure |
8 |
treatment resistant schizophrenia |
8 |
adult |
7 |
age factors |
7 |
anti-stigma campaigns |
7 |
antipsychotic agents - administration and dosage |
7 |
attitude |
7 |
behavioral symptoms - etiology - psychology - therapy |
7 |
big five |
7 |
china |
7 |
course |
7 |
duration of untreated psychosis (dup) |
7 |
effort-cost computation |
7 |
executive function - physiology |
7 |
extended early intervention |
7 |
first-episode schizophrenia spectrum disorder |
7 |
follow-up studies |
7 |
functional remission |
7 |
health service accessibility |
7 |
help-seeking |
7 |
helpโseeking |
7 |
humans |
7 |
illness disclosure |
7 |
late-onset psychosis |
7 |
latent class growth analysis |
7 |
long-term follow-up |
7 |
longitudinal course |
7 |
male |
7 |
maternal age |
7 |
medication-naรฏve |
7 |
mental health services - organization and administration |
7 |
mindfulness |
7 |
motivational impairment |
7 |
neurobiology |
7 |
neuropsychological tests |
7 |
neuropsychology |
7 |
nomenclature |
7 |
overcontrolled |
7 |
paternal age |
7 |
pathways |
7 |
persistent primary negative symptoms |
7 |
personality |
7 |
prediction |
7 |
predictive value of tests |
7 |
prognosis |
7 |
psychosocial |
7 |
psychotherapy - methods |
7 |
psychotic disorders - diagnosis - drug therapy - therapy |
7 |
ptsd symptoms, women mental health |
7 |
real-world functioning |
7 |
rehospitalization |
7 |
remission induction |
7 |
resilient |
7 |
schizophrenia - complications - diagnosis - epidemiology - therapy |
7 |
schizophrenia - diagnosis |
7 |
sex factors |
7 |
six elements |
7 |
sociodemographic correlates |
7 |
stability |
7 |
stigmatization |
7 |
stressful life event |
7 |
terminology as topic |
7 |
time factors |
7 |
treatment delay |
7 |
undercontrolled |
7 |
violence |
7 |
antipsychotic |
6 |
app |
6 |
asia |
6 |
at-risk mental states |
6 |
atโrisk mental state |
6 |
balloon analogue risk task |
6 |
blinking |
6 |
categorization |
6 |
category fluency |
6 |
chinese zodiac signs |
6 |
chizophrenia |
6 |
clinical highโrisk |
6 |
clinical predictors |
6 |
clozapine-resistant schizophrenia |
6 |
cognitive clusters |
6 |
cognitive flexibility |
6 |
cognitive heterogeneity |
6 |
cognitive insights |
6 |
concepts |
6 |
cultural sensitivity |
6 |
culture |
6 |
delivery of health care - standards |
6 |
depressive mood |
6 |
development |
6 |
digit symbol test |
6 |
digital technologies |
6 |
early intervention service |
6 |
early medical intervention - standards |
6 |
effort allocation |
6 |
effort discounting |
6 |
effort-based decision-making |
6 |
ethnic minority |
6 |
fitmind |
6 |
fractionation |
6 |
global functioning |
6 |
guideline |
6 |
history |
6 |
hospitalization |
6 |
human |
6 |
illness attributional belief |
6 |
immersive |
6 |
incidence |
6 |
internal feed-forward |
6 |
labelling |
6 |
letter |
6 |
long-term trajectories |
6 |
longitudinal negative symptoms |
6 |
mental health services - standards |
6 |
meta analysis |
6 |
mhealth |
6 |
mindfulness-based intervention |
6 |
negative treatment attitude |
6 |
outcomes |
6 |
paranoid schizophrenia |
6 |
passivity experiences |
6 |
path analysis |
6 |
pilot |
6 |
pilot trial |
6 |
predictive validity |
6 |
priority journal |
6 |
prodrome |
6 |
psychiatric comorbidity |
6 |
psychoeducation |
6 |
psychosocial functioning |
6 |
recommendation |
6 |
risk aversion |
6 |
risk taking |
6 |
riskyโgains task |
6 |
schizophrenia-spectrum disorder |
6 |
self-monitoring |
6 |
smartphone |
6 |
social anxiety |
6 |
social functioning |
6 |
social stigma |
6 |
subjective quality of life |
6 |
switching |
6 |
symptomatic remission |
6 |
systematic review |
6 |
theory of mind |
6 |
treatment |
6 |
treatment-resistant schizophrenia |
6 |
ultra-high risk |
6 |
virtual reality |
6 |
vocational outcome |
6 |
vr |
6 |
web-based |
6 |
working memory |
6 |
10-year follow-up |
5 |
10-year outcomes |
5 |
1st episode |
5 |
acupuncture |
5 |
adolescent onset |
5 |
adult onset |
5 |
adverse childhood experiences |
5 |
affiliate stigma |
5 |
aggressive behavior |
5 |
alogia |
5 |
anhedonia |
5 |
anticholinergic load |
5 |
antidepressants |
5 |
anxiety symptoms |
5 |
asian network for early psychosis |
5 |
asociality |
5 |
at-risk mental state |
5 |
attention deficit hyperactivity disorder |
5 |
attitudes towards medication |
5 |
auditory cortex |
5 |
auditory hallucination |
5 |
behavior |
5 |
blunted affect |
5 |
brain size |
5 |
caregiver |
5 |
caregiversโ distress |
5 |
cdars |
5 |
chemobrain |
5 |
chemotherapy |
5 |
chinese population |
5 |
clinical high-risk |
5 |
collective stressors |
5 |
community mental health services |
5 |
comorbidity |
5 |
compliance |
5 |
cortical thickness (brain) |
5 |
dangerous |
5 |
discrimination |
5 |
disease severity |
5 |
drug knowledge |
5 |
epidemiological study |
5 |
exercise |
5 |
express emotion |
5 |
face concern |
5 |
family caregiver |
5 |
financial deprivation |
5 |
first psychosis |
5 |
first-episode mania |
5 |
firstepisode psychosis |
5 |
firstโepisode psychosis |
5 |
formal thought disorder |
5 |
gad-7 |
5 |
gender differences |
5 |
gender effect |
5 |
general self-efficacy |
5 |
generalized anxiety disorder |
5 |
genetic high-risk |
5 |
glucose supplement |
5 |
hopelessness |
5 |
knowledge about psychosis |
5 |
knowledge of medication |
5 |
language |
5 |
language disorganization |
5 |
learned irrelevance |
5 |
longitudinal study |
5 |
major depressive episode |
5 |
media |
5 |
media report violent |
5 |
mediators |
5 |
medication |
5 |
medication discontinuation |
5 |
medication knowledge |
5 |
meta-aggregation |
5 |
metabolic screening |
5 |
mild cognitive impairment |
5 |
mindful attention |
5 |
mortality |
5 |
neurocognitive impairment |
5 |
newspapers |
5 |
nightmare |
5 |
older adults |
5 |
patient demographics |
5 |
perceived public stigma |
5 |
polypharmacy |
5 |
positive symptoms |
5 |
post-traumatic stress disorder symptoms |
5 |
predictive factors |
5 |
program |
5 |
psychiatric emergency admission |
5 |
psychiatry |
5 |
psychotic disorder |
5 |
psychotic-like experience |
5 |
qualitative |
5 |
qualitative systematic review |
5 |
rasch model |
5 |
review |
5 |
schizophrenia, pandemic |
5 |
schizophrenia-spectrum disorders |
5 |
school-based programme |
5 |
seasonality |
5 |
selective attention |
5 |
self-harm |
5 |
sex differences |
5 |
social contact |
5 |
stigma reduction |
5 |
structural equation model |
5 |
suicidal behavior |
5 |
suicidal ideation |
5 |
suicide attempt |
5 |
symptoms |
5 |
syntax |
5 |
trial |
5 |
trigeminal nerve stimulation |
5 |
unemployment |
5 |
validity |
5 |
video |
5 |
world assumptions |
5 |
youth and adult |
5 |
cancer epidemiology |
4 |
drug safety |
4 |
early detection |
4 |
gaze perception |
4 |
late-life depression |
4 |
mental disorders |
4 |
mentalisation |
4 |
multimorbidity |
4 |
net benefit |
4 |
prediction risk calculator |
4 |
prolactin |
4 |
ptsd |
4 |
public health emergency |
4 |
caregiver burden |
3 |
cbt |
3 |
clinical decisions |
3 |
cognitive behavioural therapy |
3 |
family therapy |
3 |
general population |
3 |
outbreak |
3 |
psychotic symptoms |
3 |
social support |
3 |
age-related difference |
2 |
ehealth literacy |
2 |
electronic mental health literacy |
2 |
emhl |
2 |
knowledge |
2 |
self-care |
2 |
undergraduate students |
2 |
web/app-based interventions |
2 |
adolescent and youth |
1 |
audit |
1 |
baclofen |
1 |
catatonia |
1 |
clinical governance |
1 |
clinical guidelines |
1 |
developmental stages |
1 |
dyskinesias |
1 |
dystonia |
1 |
gaba-b receptor agonists |
1 |
general hospital |
1 |
hallucinations |
1 |
mental illness |
1 |
methadone |
1 |
non-suicidal self-injury |
1 |
opiate addiction |
1 |
recurrent self-harm |
1 |
serotonin syndrome |
1 |
severe borderline personality disorder |
1 |
students |
1 |
substance withdrawal syndrome |
1 |
ยท suicide |
1 |